Varikasuvu Seshadri Reddy

Dr. Varikasuvu Seshadri Reddy


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VRVarikasuvu Seshadri Reddy
Varikasuvu Seshadri Reddy
SVSaurabh Varshney
Saurabh Varshney
NDNaveen Dutt
Naveen Dutt
MMManne Munikumar
Manne Munikumar
SAShahir Asfahan
Shahir Asfahan
PGPratima Gupta
Pratima Gupta
Hypercoagulability and the need for prioritizing coagulation markers for prognostic abilities have been highlighted in COVID-19. We aimed to quantify the associations of D-dimer with disease progression in patients with COVID-19. This systematic review and meta-analysis was registered with PROSPERO, CRD42020186661.We included 113 studies in our systematic review, of which 100 records (n = 38,310) with D-dimer data) were considered for meta-analysis. Across 68 unadjusted (n = 26,960) and 39 adjusted studies (n = 15,653) reporting initial D-dimer, a significant association was found in patients with higher D-dimer for the risk of overall disease progression (unadjusted odds ratio (uOR) 3.15; adjusted odds ratio (aOR) 1.64). The time-to-event outcomes were pooled across 19 unadjusted (n = 9743) and 21 adjusted studies (n = 13,287); a strong association was found in patients with higher D-dimers for the risk of overall disease progression (unadjusted hazard ratio (uHR) 1.41; adjusted hazard ratio (aHR) 1.10). The prognostic use of higher D-dimer was found to be promising for predicting overall disease progression (studies 68, area under curve 0.75) in COVID-19. Our study showed that higher D-dimer levels provide prognostic information useful for clinicians to early assess COVID-19 patients at risk for disease progression and mortality outcomes. This study, recommends rapid assessment of D-dimer for predicting adverse outcomes in COVID-19.

31 August 2018 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
VRVarikasuvu Seshadri Reddy
Varikasuvu Seshadri Reddy
SVSatya Prasad V
Satya Prasad V
JKJyothinath Kothapalli
Jyothinath Kothapalli
MMManne Munikumar
Manne Munikumar

1 February 2021 in Primary Care Diabetes
Verified
Journal Article
Closed access
VRVarikasuvu Seshadri Reddy
Varikasuvu Seshadri Reddy
NDNaveen Dutt
Naveen Dutt
BTBalachandar Thangappazham
Balachandar Thangappazham
SVSaurabh Varshney
Saurabh Varshney

3 February 2022 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
VRVarikasuvu Seshadri Reddy
Varikasuvu Seshadri Reddy
BTBalachandar Thangappazham
Balachandar Thangappazham
AVAlekya Vykunta
Alekya Vykunta
PDPragathi Duggina
Pragathi Duggina
MMManne Munikumar
Manne Munikumar
SASowjanya Aloori
Sowjanya Aloori
Vitamin D levels have been reported to be associated with COVID-19 susceptibility, severity and mortality events. We performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the...

8 December 2012 in Endocrine
Verified
Journal Article
Closed access
PDF file
AHA. Haribabu
A. Haribabu
VRVarikasuvu Seshadri Reddy
Varikasuvu Seshadri Reddy
CPCh. Pallavi
Ch. Pallavi
ABAparna R. Bitla
Aparna R. Bitla
ASAlok Sachan
Alok Sachan
MSM. M. Suchitra
M. M. Suchitra

4 July 2013 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
VRVarikasuvu Seshadri Reddy
Varikasuvu Seshadri Reddy
SGS. Gouroju
S. Gouroju
MSM. M. Suchitra
M. M. Suchitra
VSV. Suresh
V. Suresh
ASA. Sachan
A. Sachan
ABA. R. Bitla
A. R. Bitla
Oxidative stress as a result of disequilibrium between free radical generation and antioxidant status has been implicated in several pathologies including thyroid diseases. Studies on antioxidant status in overt (OHT) and subclinical hypothyroidism (SHT) are controversial and limited. The aim of this study was to determine the effect of OHT and SHT on antioxidant status. Thirty-six patients with OHT, 36 patients with SHT, and 39 healthy euthyroid subjects as the control group were included in the study. Plasma levels of malondialdehyde (MDA), reduced glutathione (GSH) and total antioxidant capacity (TAC) as ferric reducing ability of plasma (FRAP), and erythrocyte antioxidant enzymes superoxide dismutase (SOD), glutathione peroxidase (GPx), SOD/GPx ratios, catalase (CAT), and glutathione reductase (GR) were analyzed in all groups. MDA and GPx values were elevated, while GSH, FRAP, SOD, and SOD/GPx ratio were decreased in both patient groups compared with controls. No change in activities of CAT and GR were observed in both the patient groups. Significant differences were observed between OHT and SHT groups with high MDA, GPX and low GSH, FRAP, SOD, and SOD/GPx ratio in OHT group. Thus, hypothyroid patients have a deficient antioxidant defense in the form of decreased activity of SOD, decreased levels of FRAP and GSH along with an increase in GPx activity. The severity of the disease appears to decide the degree of deficiency and our findings also point to this, in the form of decrease in SOD, FRAP, and GSH observed being more in OHT than in SHT patients. Hormonal changes and increased lipid peroxidation, which also vary with severity of disease, appear to contribute to the antioxidant deficiency.